Summary of ROCKWELL MEDICAL, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

RMTI > SEC Filings for RMTI > Form 8-K on 5-Feb-2013

All Recent SEC Filings

Show all filings for ROCKWELL MEDICAL, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ROCKWELL MEDICAL, INC.

5-Feb-2013

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On February 4, 2013, Rockwell Medical, Inc. (the "Company") issued a press release announcing top-line results from the PRIME clinical study of Soluble Ferric Pyrophosphate ("SFP"), its investigational iron-delivery drug currently in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

Exhibit 99.1 Press Release, dated February 4, 2013

Add RMTI to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for RMTI - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.